00:00
What are the
clinical signs of COPD? Well, with mild disease,
in fact, there will be very little to find
when they examine the patient, but more moderate,
more severe disease, it may be evident that
they have respiratory difficulty. They may
be breathless moving around the examination
room, they may have an increased respiratory rate
at rest. They may have to use their accessory
muscles to breathe and there might be excessive
abdominal movement. And patients with more
severe disease and exacerbations could show
pursed lip breathing. When you look at the
chest, it may obviously be hyperexpanded with
a horizontal angle to the ribs and increased
anterior-posterior diameter, the so-called
'barrel chest'. There may be tracheal tug
with the cricoid cartilage coming down on
inspiration towards the sternal notch.
00:41
And when you examine the chest directly, the expansion
will be reduced bilaterally on inspiration
and there will be loss of the normal dull
percussion note that you normally find over
the liver and the heart, and the lungs might
be expanded below the level of the 10th vertebra
posteriorly. When you listen to the lungs
actually wheeze,
although it is a sign of the COPD and airways
disease, is not universally present. In fact,
it's probably present in fewer patients, than
no wheeze. What they do have, is a prolonged
expiratory phase and they have quiet breath
sounds all over their chest, that's a very
common sign. Patients with very severe disease
may have the signs of complicating cor pulmonale,
raised JVP, oedema etc. There's often a
description of clinical phenotypes
of COPD. As I mentioned earlier, there's an
admixture of different pathologies that
patients with COPD have and that might dictate
the clinical phenotype they present with.
01:44
The two extremes of this phenotype is the
blue bloater and the pink puffer. Now there
are probably not terribly useful clinical
terms but they are useful with illustrating
the different types of pathology mixtures
you may get in somebody with COPD.
02:00
So, for example, a pink puffer, the emphysema
component may be dominant in their pathology
and that's associated with a lot of muscle
wasting and cachexia and a rapid respiratory
rate, using accessory muscles with pursed
lips breathing, but with no real cyanosis
or oedema, because the patient is maintaining
their respiratory function without tipping
over into type 2 respiratory failure or significant
hypoxia by compensating with a high respiratory
rate. The blue bloater on the other hand,
airways obstruction is dominant, there is
not much emphysema and they seem to have chronic
type 2 respiratory failure with hypercapnia
and some cor pulmonale. And that means they're
cyanosed, they have a relatively low respiratory
rate, they tend to be overweight, and they
have peripheral oedema. But this a spectrum
and patients frequently have a mixture of
these features and even can go from one to
the other to a certain extent. So many patients
with emphysema, although they are not hypoxic
initially, eventually they will develop hypoxia
and cor pulmonale and will present with cyanosis
and oedema etc etc. So how do we
confirm the suspected diagnosis
of COPD? Well that's easy enough. We need
to do some lung function tests, we need to
record an FEV1 and FVC. Both will be reduced
at a significant airways obstruction, but
the FEV1 will be reduced proportionately further
than the FVC because of the airflow obstruction,
and that means the ratio of the two will fall.
So for example in the spirometry shown here
on this slide, the expected value for this
patient will be 3.9 and 4, and that gives
a ratio of FEV1 to FVC over the high 70s. However,
the obtained values was 0.9 and 1.6.
03:44
Those are both much lower than they should be, but
also the ratio of FEV1 to FVC is closer to
50%, around 60% there. And the thing about
the airways obstruction in COPD is that it's
largely irreversible, there might be a small
uplift with bronchodilators, but often there is
no change at all in FEV1, and there's always
a persisting level of airways obstruction.
04:11
The peak flow records are not so useful in
patients with COPD as they are of asthma,
because the peak flow does not vary as much,
and therefore is not a useful way of analyzing
whether the patient is in exacerbation or
is deteriorating in some way. A very important
point which follows from the slides that we
discussed earlier is that the FEV1 over time
tells you how the patient is doing. And if
the patient has an FEV1 less than 50%, that's
probably severe COPD.